J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India
· Delayed Price · Currency is INR 1,703.80
+39.85 (2.39%)
At close: May 20, 2025
BOM:506943 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 6,596 | 5,526 | 4,098 | 3,854 | 4,480 | Upgrade
|
| Depreciation & Amortization | 1,710 | 1,352 | 1,120 | 722.41 | 683.27 | Upgrade
|
| Other Amortization | - | - | - | 4.19 | 3.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.1 | 2.51 | 0.4 | -24.05 | -524.37 | Upgrade
|
| Loss (Gain) From Sale of Investments | -322.1 | -327.43 | -69 | -350.43 | -505.5 | Upgrade
|
| Stock-Based Compensation | 549 | 401.4 | 669.02 | 626.54 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 42.9 | 99.5 | 30.71 | - | 7.96 | Upgrade
|
| Other Operating Activities | 378.8 | 922.12 | 563.2 | -106.65 | -54.45 | Upgrade
|
| Change in Accounts Receivable | -498 | -666.84 | -194.92 | -2,928 | -705.99 | Upgrade
|
| Change in Inventory | -264.4 | -742.44 | -371.67 | -625.14 | -700.86 | Upgrade
|
| Change in Accounts Payable | 834.2 | 1,323 | 440.44 | 529.3 | 464.75 | Upgrade
|
| Operating Cash Flow | 9,025 | 7,890 | 6,286 | 1,701 | 3,148 | Upgrade
|
| Operating Cash Flow Growth | 14.37% | 25.51% | 269.50% | -45.95% | 14.16% | Upgrade
|
| Capital Expenditures | -975.9 | -1,261 | -724.61 | -628.7 | -477.73 | Upgrade
|
| Sale of Property, Plant & Equipment | 11.1 | 9.26 | 7.72 | 77.75 | 483.89 | Upgrade
|
| Cash Acquisitions | - | -99.1 | - | - | -85 | Upgrade
|
| Sale (Purchase) of Intangibles | -227.1 | -1,314 | -6,853 | -6,439 | - | Upgrade
|
| Investment in Securities | 754.8 | -1,496 | -1,863 | 7,002 | -2,241 | Upgrade
|
| Other Investing Activities | -2,522 | 36.44 | -125.78 | 11.29 | 12.74 | Upgrade
|
| Investing Cash Flow | -2,959 | -4,124 | -9,559 | 23.2 | -2,307 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 3.22 | Upgrade
|
| Long-Term Debt Issued | - | - | 6,086 | - | - | Upgrade
|
| Total Debt Issued | - | - | 6,086 | - | 3.22 | Upgrade
|
| Short-Term Debt Repaid | -3,439 | -66.3 | -195.25 | -3.27 | - | Upgrade
|
| Long-Term Debt Repaid | -131 | -1,897 | -956.86 | -80.38 | -81.56 | Upgrade
|
| Total Debt Repaid | -3,570 | -1,964 | -1,152 | -83.65 | -81.56 | Upgrade
|
| Net Debt Issued (Repaid) | -3,570 | -1,964 | 4,934 | -83.65 | -78.34 | Upgrade
|
| Issuance of Common Stock | 240 | 199.91 | 84.83 | - | - | Upgrade
|
| Common Dividends Paid | -2,370 | -1,570 | -1,276 | -1,276 | -732.4 | Upgrade
|
| Other Financing Activities | -96.2 | -407.09 | -308.98 | -24.57 | -63.49 | Upgrade
|
| Financing Cash Flow | -5,797 | -3,741 | 3,434 | -1,384 | -874.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | -0.16 | 0.29 | 0.01 | 0.36 | Upgrade
|
| Net Cash Flow | 268.7 | 24.88 | 161.96 | 340.7 | -32.78 | Upgrade
|
| Free Cash Flow | 8,049 | 6,629 | 5,562 | 1,073 | 2,670 | Upgrade
|
| Free Cash Flow Growth | 21.41% | 19.19% | 418.51% | -59.83% | 31.68% | Upgrade
|
| Free Cash Flow Margin | 20.54% | 19.03% | 17.66% | 4.42% | 13.07% | Upgrade
|
| Free Cash Flow Per Share | 50.71 | 41.80 | 35.51 | 6.93 | 17.27 | Upgrade
|
| Cash Interest Paid | 96.2 | 407.09 | 308.98 | 24.57 | 63.49 | Upgrade
|
| Cash Income Tax Paid | 2,007 | 1,279 | 885.94 | 1,346 | 1,417 | Upgrade
|
| Levered Free Cash Flow | 6,408 | 3,724 | -2,598 | -5,711 | 2,006 | Upgrade
|
| Unlevered Free Cash Flow | 6,481 | 3,997 | -2,380 | -5,685 | 2,048 | Upgrade
|
| Change in Net Working Capital | -44.83 | -84.22 | 315.48 | 2,932 | 1,220 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.